Sacral neuromodulation in nursing home residents: Predictors of success and complications in a national cohort of older adults
Neurourology and Urodynamics · 2024
DOI: 10.1002/nau.25465 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurourology and Urodynamics, 2024. Verfasst von Leo D Dreyfuss und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Weill Cornell Medical Center, New York, New York, USA. Hauptthemen laut MEDLINE: Nursing Homes, Urinary Bladder, Overactive. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIA NIH HHS, NIH-NIA.
Themen: Langzeitpflege, Gerontologische Pflege
Abstract (Originalsprache)
Aims
There is limited evidence to support the efficacy of sacral neuromodulation (SNM) for older adults with overactive bladder (OAB). This study aims to report outcomes following SNM among nursing home (NH) residents, a vulnerable population with high rates of frailty and comorbidity.
Methods
This is a retrospective cohort study of long‐stay NH residents who underwent a trial of percutaneous nerve evaluation (PNE) or Stage 1 permanent lead placement (Stage 1) between 2014 and 2016. Residents were identified using the Minimum Data Set linked to Medicare claims. The primary outcome of this study was successful progression from trial to implant. Rates of 1‐year device explant/revisions were also investigated.
Results
Trial of SNM was observed in 1089 residents (mean age: 77.9 years). PNE was performed in 66.9% of residents and 33.2% underwent Stage 1. Of Stage 1 procedures, 23.8% were performed with simultaneous device implant (single‐stage). Overall, 53.1% of PNEs and 72.4% of Stage 1 progressed to device implant, which was associated with Stage 1 procedure versus PNE (adjusted relative risk [aRR]: 1.34; 95% confidence interval [95% CI]: 1.21–1.49) and female versus male sex (aRR: 1.26; 95% CI: 1.09–1.46). One‐year explant/revision was observed in 9.3% of residents (6.3% for PNE, 10.5% for Stage 1, 20.3% single‐stage). Single stage procedure versus PNE was significantly associated with device explant/revision (aRR: 3.4; 95% CI: 1.9–6.2).
Conclusions
In this large cohort of NH residents, outcomes following SNM were similar to previous reports of younger healthier cohorts. Surgeons managing older patients with OAB should use caution when selecting patients for single stage SNM procedures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Weill Cornell Medical Center, New York, New York, USA.
- Department of Urology, University of California-San Francisco, San Francisco, California, USA.
- Department of Obstetrics and Gynecology, University of California, San Francisco, California, USA.
- Division of Geriatrics, University of California-San Francisco, San Francisco, California, USA.
- Department of Epidemiology and Biostatistics, University of California-San Francisco, San Francisco, California, USA.
Förderung
- NIDDK NIH HHS
- NIA NIH HHS
- NIH-NIA
Zitieren
APA
Dreyfuss, L. D., Nik-Ahd, F., Wang, L., Shatkin-Margolis, A., Covinsky, K., John Boscardin, W., & Suskind, A. M. (2024). Sacral neuromodulation in nursing home residents: Predictors of success and complications in a national cohort of older adults. Neurourology and Urodynamics. https://doi.org/10.1002/nau.25465
Vancouver
Dreyfuss LD, Nik-Ahd F, Wang L, Shatkin-Margolis A, Covinsky K, John Boscardin W, et al. Sacral neuromodulation in nursing home residents: Predictors of success and complications in a national cohort of older adults. Neurourology and Urodynamics. 2024. doi:10.1002/nau.25465
BibTeX
@article{Dreyfuss2024,
author = {Dreyfuss, Leo D and Nik-Ahd, Farnoosh and Wang, Lufan and Shatkin-Margolis, Abigail and Covinsky, Kenneth and John Boscardin, W and Suskind, Anne M},
title = {Sacral neuromodulation in nursing home residents: Predictors of success and complications in a national cohort of older adults},
journal = {Neurourology and Urodynamics},
year = {2024},
doi = {10.1002/nau.25465}
}
EUVIMED